Product/Composition:- | Ranitidine tablets |
---|---|
Strength:- | 75 mg, 150 mg, 300 mg |
Form:- | Tablet |
Reference Brands:- | Zantac(US & EU)- dis.contd in many markets |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Ranitidine tablets are H2 receptor antagonists that block histamine receptors in the stomach lining, reducing acid secretion. They provide relief from heartburn, GERD, ulcers, and acid indigestion, promote healing of ulcers, and prevent acid-related damage, improving comfort and preventing complications associated with excessive gastric acid.
Ranitidine tablets were widely used for acid-related disorders in the US and EU, supported by comprehensive regulatory dossiers demonstrating safety, efficacy, and manufacturing quality. However, due to concerns over NDMA impurities, many countries, including the US and EU, have withdrawn ranitidine products from the market. Regulatory authorities have implemented strict testing and monitoring protocols for existing stocks. For detailed information on regulatory status, dossiers, and licensing requirements for alternatives, visit Pharmatradz. Stay informed on the latest updates regarding the regulatory landscape for ranitidine and safe alternatives in global markets.